Trial Profile
Comparative crossover study of OROS (methylphenidate HCl), Ritalin, and placebo in children with ADHD [attention deficit-hyperactivity disorder]
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 27 Jul 2007
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors ALZA Corporation
- 19 Nov 2006 New trial record.